Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation/Experiment 4

From BugSigDB


Reviewed Marked as Reviewed by KateRasheed on 2025-7-10

Curated date: 2025/04/17

Curator: Tosin

Revision editor(s): Tosin

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Chronic constipation Chronic constipation,Infrequent bowel movements,chronic constipation
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Healthy Controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
Functional constipation (FC) group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with Functional constipation (FC)
Group 0 sample size Number of subjects in the control (unexposed) group
6
Group 1 sample size Number of subjects in the case (exposed) group
6

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
BGISEQ-500 Sequencing

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2.5

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Simpson Estimator of species richness and species evenness: more weight on species evenness
unchanged

Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-7-10

Curated date: 2025/04/17

Curator: Tosin

Revision editor(s): Tosin

Source: Figure 3E, Table S5

Description: Significant differential taxa between Healthy controls (HC) and Functional Constipation (FC) group using LeFse analysis

Abundance in Group 1: increased abundance in Functional constipation (FC) group

NCBI Quality ControlLinks
Anaerostipes caccae
Clostridium sp. AF34-10BH
Clostridium sp. AF36-18BH
Clostridium sp. TF08-15
Coprococcus eutactus
Eubacterium
Eubacterium ventriosum
Lachnospira eligens
Lachnospiraceae bacterium GAM79
Odoribacter splanchnicus
Phascolarctobacterium faecium
Roseburia hominis
unclassified Bacteria
unclassified Eubacterium
Bacteroides fluxus
Bacteroides sp. AM54-2NS
Bacteroides sp. 4_1_36
Clostridium sp. AM34-9AC

Revision editor(s): Tosin

Signature 2

Reviewed Marked as Reviewed by KateRasheed on 2025-7-10

Curated date: 2025/04/18

Curator: Tosin

Revision editor(s): Tosin

Source: Figure 3E, Table S5

Description: Significant differential taxa between Healthy controls (HC) and Functional Constipation (FC) group using LeFse analysis

Abundance in Group 1: decreased abundance in Functional constipation (FC) group

NCBI Quality ControlLinks
Clostridium paraputrificum
Fusobacterium ulcerans
Fusobacterium mortiferum
Eubacterium sp. CAG:38
Clostridium disporicum

Revision editor(s): Tosin